Efor strengthens its presence in Asia with the opening of a new office in Shanghai

Efor continues its international expansion with the inauguration of its new Shanghai offices. This milestone marks the full integration of No Deviation’s teams into the group and demonstrates our commitment to sustainably strengthening our presence in the Asia-Pacific region to better support Life Sciences players across the area.

At the heart of a dynamic ecosystem

Shanghai has become a key hub for the pharmaceutical, biotech, and medtech industries. Through this office, Efor positions itself close to its clients and local challenges in an environment that is rapidly evolving.
This opening follows the integration of No Deviation into Efor, enhancing the group’s expertise in Project Management, Commissioning, Qualification & Validation, Regulatory Affairs, and Automation Engineering.

Local presence, global expertise

Already established in Asia and the Middle East, with an APAC headquarters in Singapore and over 300 experts across China, India, Malaysia, Indonesia, Taiwan, and the United Arab Emirates, Efor continues to pursue its ambition: combining local presence with international excellence.
Our on-site teams benefit from:

• direct access to worldwide expertise
• support aligned with international regulatory standards (FDA, EMA)
• the ability to respond quickly and effectively across the Asia-Pacific region

A trusted partner for Life Sciences players in Asia

With an already strong footprint in the Asia-Pacific, the opening of these new offices further strengthens a growing collective.
Efor confirms its ability to support partners at every stage of their projects:

• product development
• regulatory compliance
• industrialization
• continuous performance improvement

By combining technical expertise, quality, and local presence, Efor positions itself as a trusted partner to support healthcare innovation in the region.
Our ambition remains unchanged: to be where our clients need us and to build sustainable solutions together for the long term.